Skip to main content
Premium Trial:

Request an Annual Quote

Applied DNA Sciences Closes $7.4M Financing Round

NEW YORK, Feb. 15 (GenomeWeb News) - Applied DNA Sciences has raised $7.36 million from a Dec. 30, 2004, stock offering, the Los Angeles-based company said today.


The majority of the funds will be used to "vigorously accelerate" marketing, sales, and distribution programs for the company's DNA-based security products, Applied DNA Sciences said in a statement. The company also said that it will use a portion of the funding to establish a US-based laboratory to produce the security products.


Applied DNA Sciences has raised a total of just over $10 million in venture capital, according to a company spokesperson. In addition, he said that Taiwanese company Biowell has spent approximately $10 million to create the DNA security technology, to which Applied DNA Sciences is in the process of acquiring all rights, title, and interest.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.